Repair Biotechnologies Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $11.4M

  • Investors
  • 14

Repair Biotechnologies General Information

Description

Operator of a preclinical biotechnology company intended to develop drugs for cholesterol and aging-related diseases. The company's cholesterol-degrading platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemia, and other conditions in which excess or modified cholesterol drives pathology, enabling healthcare providers to rapidly and dramatically reduce atherosclerotic plaque in arteries, the cause of stroke, heart attack, and other cardiovascular diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 841 East Fayette Street
  • Syracuse, NY 13210
  • United States
+1 (315)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 841 East Fayette Street
  • Syracuse, NY 13210
  • United States
+1 (315)

Repair Biotechnologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Repair Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 25-Nov-2025 $11.4M Completed Pre-Clinical Trials
3. Seed Round 21-Sep-2023 Completed Pre-Clinical Trials
2. Seed Round 01-Sep-2020 $2.85M $2.88M Completed Pre-Clinical Trials
1. Accelerator/Incubator 10-Aug-2018 $25K $25K Completed Pre-Clinical Trials
To view Repair Biotechnologies’s complete valuation and funding history, request access »

Repair Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed B-3
Seed B-2
Seed B-1
Seed B
Seed A-6
Seed A-5
Seed A-4
Seed A-3
Seed A-2 109,365 $0.000010 $2.51 $2.51 1x $2.51 0.41%
Seed A-1 170,125 $0.000010 $0.29 $0.29 1x $0.29 0.64%
To view Repair Biotechnologies’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Repair Biotechnologies Patents

Repair Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025242780-A1 Atherosclerotic plaque reduction treatments and compositions Pending 25-Mar-2024
WO-2025207597-A1 Atherosclerotic plaque reduction treatments and compositions Pending 25-Mar-2024
JP-2024501867-A Compositions for the treatment, prophylactic treatment and use thereof of hepatocellular carcinoma Pending 30-Dec-2020
AU-2021416182-A1 Hepatocellular carcinoma treatments, prophylactic therapies, and compositions for use therewith Pending 30-Dec-2020
AU-2021416182-A9 Hepatocellular carcinoma treatments, prophylactic therapies, and compositions for use therewith Pending 30-Dec-2020 A61K38/443
To view Repair Biotechnologies’s complete patent history, request access »

Repair Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Repair Biotechnologies Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
LongGame Ventures Venture Capital Minority
100 Plus Capital Impact Investing Minority
Bioverge Venture Capital Minority
Healthspan Capital Venture Capital Minority
quadraScope Ventures Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Repair Biotechnologies FAQs

  • When was Repair Biotechnologies founded?

    Repair Biotechnologies was founded in 2018.

  • Where is Repair Biotechnologies headquartered?

    Repair Biotechnologies is headquartered in Syracuse, NY.

  • What is the size of Repair Biotechnologies?

    Repair Biotechnologies has 10 total employees.

  • What industry is Repair Biotechnologies in?

    Repair Biotechnologies’s primary industry is Drug Discovery.

  • Is Repair Biotechnologies a private or public company?

    Repair Biotechnologies is a Private company.

  • What is the current valuation of Repair Biotechnologies?

    The current valuation of Repair Biotechnologies is .

  • What is Repair Biotechnologies’s current revenue?

    The current revenue for Repair Biotechnologies is .

  • How much funding has Repair Biotechnologies raised over time?

    Repair Biotechnologies has raised $22.9M.

  • Who are Repair Biotechnologies’s investors?

    LongGame Ventures, 100 Plus Capital, Bioverge, Healthspan Capital, and quadraScope Ventures are 5 of 14 investors who have invested in Repair Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process